BIOMAT Database Logo BIOMAT Database Logo

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. 2001

R J O'Brien, and P P Nunn
Special Programme for Research and Training in Tropical Disease, World Health Organization, Geneva, Switzerland.

UI MeSH Term Description Entries
D007373 Interinstitutional Relations The interactions between representatives of institutions, agencies, or organizations. Interagency Relations,Interagency Relation,Interinstitutional Relation,Relation, Interagency,Relation, Interinstitutional,Relations, Interagency,Relations, Interinstitutional
D007391 International Cooperation The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest. Foreign Aid,Treaties,Aid, Foreign,Cooperation, International,Treaty
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D012109 Research Support as Topic Work about financial support of research activities. Grants and Subsidies, Research,Subsidies, Research,Research Subsidies,Research Subsidy
D003140 Communicable Disease Control Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man. Flatten the Curve of Epidemic,Flattening the Curve, Communicable Disease Control,Parasite Control,Control, Communicable Disease,Control, Parasite
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014943 Global Health A multi- and interdisciplinary field concerned with improving health and achieving equity in health for all people. It transcends national boundaries, promotes cooperation and collaboration within and beyond health science fields, and combines population-based disease prevention with individually-based patient care. International Health Problems,World Health,International Health,Worldwide Health,Health Problem, International,Health Problems, International,Health, Global,Health, International,Health, World,Health, Worldwide,Healths, International,International Health Problem,International Healths,Problem, International Health,Problems, International Health
D018088 Tuberculosis, Multidrug-Resistant Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS. Tuberculosis, Drug-Resistant,Tuberculosis, MDR,Tuberculosis, Multi-Drug Resistant,Drug-Resistant Tuberculosis,MDR Tuberculosis,Multi-Drug Resistant Tuberculosis,Multidrug-Resistant Tuberculosis,Tuberculosis, Drug Resistant,Tuberculosis, Multi Drug Resistant,Tuberculosis, Multidrug Resistant

Related Publications

R J O'Brien, and P P Nunn
[New drugs, new obstacles in the fight against HIV].
January 1996, SIDAhora : un proyecto del Departamento de Publicaciones del PWA Coalition, NY,
R J O'Brien, and P P Nunn
Opportunities afforded by new drugs for tuberculosis.
June 2010, The Lancet. Infectious diseases,
R J O'Brien, and P P Nunn
The next Black America: Obstacles amidst opportunities for Black families.
September 2015, The American journal of orthopsychiatry,
R J O'Brien, and P P Nunn
New methods for new questions: obstacles and opportunities.
March 2008, Developmental psychology,
R J O'Brien, and P P Nunn
Opening opportunities for new drugs against neglected diseases.
March 2008, ChemMedChem,
R J O'Brien, and P P Nunn
New drugs against tuberculosis.
May 1969, Lancet (London, England),
R J O'Brien, and P P Nunn
New drugs against tuberculosis.
June 1969, Lancet (London, England),
R J O'Brien, and P P Nunn
New drugs against tuberculosis.
January 1967, British medical journal,
R J O'Brien, and P P Nunn
Next steps against AIDS.
April 2001, Nature,
R J O'Brien, and P P Nunn
Tuberculosis in the time of Ebola: obstacles and opportunities.
November 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!